|
Why Clinical Research with GPs ? |
| Print |
|
Usually Clinical Trials in phase II and III occur in a hospital, but
- You don’t find all the pathologies in the hospital, for example flu, anginas, mild hypertension, naive diabetes, …
- The pharmaceutical innovations often appear by waves in the same category of pathologies, the specialist’s pool of patients may be exhausted.
- A long-term follow-up may be difficult at the hospital, whereas some studies of morbi-mortality are spread over 3 or 5 years.
- Thanks to the proximity with his patient, the general practitioner is better informed of any incident and will reduce the number of lost of sight patients.
- Thanks to their long-lasting relation, the GP has a better knowledge of the medical history and can better evaluate the reliability of the patient.
- The GP has a global sight of his patient’s health and is best placed to appreciate any evolution.
- The products are tested under their real conditions of use.
Let us not forget that GPs are in first line to prescribe most of the drugs !
|
